<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-2-00071</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=74 g=1 f=1 --> References <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> 1. Arthritis Medical Information Series: Sjogren's Syndrome. Atlanta: Arthritis Foundation, 1988. <!-- PJG 0012 frnewline --> 2. Peterson JK. Xerostomia. Scand J. Rheumatol 1986;61(suppl):185_189. <!-- PJG 0012 frnewline --> 3. Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow in patients with Sjogren's syndrome. J Dent Res. 1988;67(60):1334_1337. <!-- PJG 0012 frnewline --> 4. Fox PC, Baum BJ, Mandel ID. Pilocarpine for the treatmnt of xerostomia associated with salivary gland dysfunction. Oral Surg 1986;61(3):243_248. <!-- PJG 0012 frnewline --> 5. Fox PC, van der Ven PF, Sonies BC, et al. Xerostomia: Evaluation of a symptom with increasing significance. J Am Dent Assoc. 1985;110:519_525. <!-- PJG 0012 frnewline --> 6. Rhodus NL. Xerostomia: An increasingly significant dental management challenge. Northwest Dentistry 1987;66(4):14&hyph;18. <!-- PJG 0012 frnewline --> 7. Weiss WW, Brennan HS, Katz P, et al. Use of electronic stimulator for the treatment of dry mouth, J Oral Maxilo-fac Surg 1986;41:845_850. <!-- PJG 0012 frnewline --> 8. Talal N. Sjogren's syndrome, in Wyngaarden JB, Smith LH (Eds): Cecil Textbook of Medicine (17th ed). Philadelphia: Saunders, 1985, pp. 1936_1937. <!-- PJG 0012 frnewline --> 9. Whaley K, Alspaugh MA. Sjogren's syndome, in Kelly WN, Harris ED, Ruddy s, et al(Eds): Textbook of Rheumatology (vol 1). Philadelphia: Saunders, 1985, pp. 956_973. <!-- PJG 0012 frnewline --> 10. Weerkamp AH, Wagner K, Vissinic A, et al. Effect of the application of a mucin-based saliva substitute on the oral microflora of xerostomic patients. Oral Pathol 1987;16(9):474_478. <!-- PJG 0012 frnewline --> 11. Scully C. Sjogren's syndrome: Clinical and laboratory features, immunopathogenesis, and management. Oral surg 1986;62(5):510_523. <!-- PJG 0012 frnewline --> 12. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomic and objective measures of salivary gland performance. J Am Dent Assoc 1987;115:581_584. <!-- PJG 0012 frnewline --> 13. Talal N. Overview of Sjogren's syndrome. J Dent Res 1987;66(special issue): 672_674. <!-- PJG 0012 frnewline --> 14. Vissink A, Johannes's-Gravenmade E, Panders AK, et al. Treatment of Hyposalivation. Ear Nose Throat J 1988;67:179_185. <!-- PJG 0012 frnewline --> 15. Levine MJ, Aquirre A, Hatton MN, et al. Artificial salivas: Present and future. J Dent Res 1987;66:693_698. <!-- PJG 0012 frnewline --> 16. Brastings ED. Saliva, xerostomia, and salivary substitutes. Pa Dent J 1987;54(5):23_24. <!-- PJG 0012 frnewline --> 17. Duxbury AJH, Thakker NS, Wastell DG. A double-blind cross-over trial of a mucin-containing artificial saliva. Br Dent J 1989;166:115_120. <!-- PJG 0012 frnewline --> 18. Vissink KA, Panders AK,'sGravenmade EJ, et al. Treatment of oral symptoms in Sjogren's syndrome. Scand J Rheumatol 1986;61(suppl):270_273. <!-- PJG 0012 frnewline --> 19. Garrett JR. The proper role of nerves in salivary secretion: A review. J Dent Res 1987;66(2):387_397. <!-- PJG 0012 frnewline --> 20. Food and Drug Administration. Summary of Safety and Effectiveness Data: Salivation Electro-Stimulation Device, (unpublished report), 1988. <!-- PJG /ITAG -->  <!-- PJG QTAG 03 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;12457 Filed 5&hyph;20&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4121&hyph;01&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            